High levels of total IGF-1R were associated with higher tumour grade while higher levels of cytoplasmic IGF-1R were linked to a greater risk of post-radiotherapy recurrence in prostate cancer patients (Aleksic et al., 2017). Here, IGF1R is linked to neoplasm.